HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Leonardo J M Carvalho Selected Research

Cerebral Malaria

3/2021Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria.
1/2021Whole blood transfusion improves vascular integrity and increases survival in artemether-treated experimental cerebral malaria.
1/2019L-arginine supplementation and thromboxane synthase inhibition increases cerebral blood flow in experimental cerebral malaria.
10/2018Reversal of cerebrovascular constriction in experimental cerebral malaria by L-arginine.
3/2018Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
10/2015NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.
5/2015From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
11/2013Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
7/2013A chronic scheme of cranial window preparation to study pial vascular reactivity in murine cerebral malaria.
4/2013Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Leonardo J M Carvalho Research Topics

Disease

17Cerebral Malaria
03/2021 - 01/2006
13Infections
03/2021 - 02/2005
9Malaria
01/2021 - 02/2005
5Parasitemia
07/2020 - 02/2005
4Inflammation (Inflammations)
03/2018 - 06/2011
3Anemia
01/2021 - 01/2012
2Hemorrhage
05/2011 - 03/2010
1Coma (Comas)
01/2021
1Babesiosis (Piroplasmosis)
07/2020
1Hypoxia (Hypoxemia)
01/2019
1Brain Ischemia (Cerebral Ischemia)
01/2019
1Ischemia
01/2019
1Necrosis
03/2018
1Falciparum Malaria (Plasmodium falciparum Malaria)
01/2017
1Glucosephosphate Dehydrogenase Deficiency
05/2015
1Acute Disease
03/2015
1Convalescence
03/2015
1Hyperplasia
03/2015
1Hypotension (Low Blood Pressure)
04/2013
1Bradycardia
04/2013
1Encephalitis (Encephalitis, Rasmussen)
06/2012
1Communicable Diseases (Infectious Diseases)
12/2005

Drug/Important Bio-Agent (IBA)

8Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019 - 05/2011
5ArtemetherFDA Link
01/2021 - 03/2010
4artemisinin (artemisinine)IBA
03/2021 - 05/2015
4ArtesunateIBA
07/2020 - 04/2013
4Antimalarials (Antimalarial Agents)IBA
01/2017 - 04/2013
4VaccinesIBA
01/2017 - 02/2005
3Mefloquine (Lariam)FDA LinkGeneric
07/2020 - 08/2013
3Arginine (L-Arginine)FDA Link
01/2019 - 01/2012
2perillyl alcoholIBA
03/2021 - 03/2018
2CytokinesIBA
03/2018 - 04/2015
2Interleukin-12 (IL 12)IBA
03/2018 - 03/2015
2Interleukin-6 (Interleukin 6)IBA
03/2018 - 03/2015
2Chloroquine (Aralen)FDA LinkGeneric
03/2015 - 08/2013
2Nimodipine (Modus)FDA LinkGeneric
04/2013 - 03/2010
2AntibodiesIBA
06/2011 - 02/2005
1tafenoquineIBA
07/2020
18-aminoquinolineIBA
07/2020
1ThromboxanesIBA
01/2019
1InterleukinsIBA
03/2018
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
03/2018
1InterferonsIBA
03/2018
1Liposomes (Liposome)IBA
01/2017
1Clodronic Acid (Clodronate)IBA
01/2017
11,2,5-oxadiazole 2-oxideIBA
10/2015
1artenimol (dihydroartemisinin)IBA
10/2015
1Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
05/2015
1Heme (Haem)IBA
05/2015
1Antineoplastic Agents (Antineoplastics)IBA
05/2015
1RRx-001IBA
05/2015
1Interleukin-2 (IL2)IBA
03/2015
1hemozoinIBA
03/2015
1Interleukin-10 (Interleukin 10)IBA
03/2015
1Hemoglobins (Hemoglobin)IBA
11/2013
1Nitroglycerin (Dynamite)FDA LinkGeneric
11/2013
1Quinine (Quinson)FDA Link
08/2013
1Nitric Oxide Synthase (NO Synthase)IBA
01/2013
1dipropylenetriamine-NONOateIBA
06/2012
1S-NitrosoglutathioneIBA
06/2012
1Glutathione (Reduced Glutathione)IBA
06/2012
1sapropterin (tetrahydrobiopterin)FDA Link
01/2012
1Sodium NitriteIBA
01/2012
1Sildenafil Citrate (Viagra)FDA Link
01/2012
1AlbuminsIBA
06/2011
1Fluorescein-5-isothiocyanate (FITC)IBA
06/2011
1P-SelectinIBA
06/2011
1Amodiaquine (Camoquin)FDA Link
05/2011
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
03/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2006
1Dehydroepiandrosterone (DHEA)IBA
01/2006
1Estradiol (Delestrogen)FDA LinkGeneric
01/2006
1Proteins (Proteins, Gene)FDA Link
12/2005
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
12/2005
1Peptides (Polypeptides)IBA
12/2005
1Immunoglobulin G (IgG)IBA
12/2005
1Malaria VaccinesIBA
12/2005
1Glutamic Acid (Glutamate)FDA Link
12/2005
1Subunit VaccinesIBA
12/2005
1Monatide (IMS 3015)IBA
02/2005
1aluminum sulfate (alum)IBA
02/2005

Therapy/Procedure

6Therapeutics
03/2021 - 01/2012
1Blood Transfusion (Blood Transfusions)
01/2021
1Intranasal Administration
03/2018
1Splenectomy
01/2017
1Aftercare (After-Treatment)
03/2015
1Craniotomy
07/2013
1Injections
01/2012
1Castration
01/2006